|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
|
Theodore Friedmann, M.D., Chair, NIH RAC |
|
|
|
Webcast
|
|
|
|
|
Data Management Report |
|
|
|
Webcast
|
|
|
|
|
Update on the Development of a Mechanism to Apprise the RAC of Investigator and Institutional Responses to RAC Reviews |
|
|
|
Cheryl McDonald, M.D., NIH OBA Staff
Thomas Shih, M.D., Ph.D., NIH OBA Staff |
|
|
|
Webcast
Slides
|
|
|
|
|
|
Amendments and Updates to Human Gene Transfer Protocol #0010-419 |
|
|
|
Intratumoral Injections of a Replication-Incompetent Adenoviral Vector Encoding a Factor VII Immunoconjugate to Induce a Cytolytic Immune Response Against Melanoma Tumors: A Pilot Trial |
|
|
|
Albert B. Deisseroth, M.D., Ph.D.
Sidney Kimmel Cancer Center, San Diego, CA |
|
|
|
Webcast
Slides
|
|
|
|
|
|
Discussion of Human Gene Transfer Protocol #0310-610 |
|
|
|
A Phase I/II Study of the Treatment of Recurrent or Progressive Malignant Glioma Using Autologous Bone Marrow-Derived Stromal Cells (BMSC) Nonvirally Transduced to Express IL-12 |
|
|
|
Tom Mikklesen, M.D., Henry Ford Cancer Center, Detroit, MI |
|
|
|
Webcast
Slides
|
|
|
|
|
Educational Seminar Series on Retroviruses: "Global Site Preferences for MLV and HIV-1 Proviral Integration in the Human Genome" |
|
|
|
Shawn M. Burgess, Ph.D., National Human Genome Research Institute, NIH |
|
|
|
Webcast
Slides
|
|
|
|
|
ADJOURN |
|
|
|
Top of Page |
|